Company / Operating Cash Flow per Share
Niagen Bioscience, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.17
FY2025
5-year range
-$0.35 / $0.17
FY2021-FY2025
Trend
+84.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has increased for 3 consecutive years, from $-0.35 in FY2022 to $0.17 in FY2025.
Based on SEC 10-K filings.
0.17 in FY2025.
Improved from $-0.20 to $0.17 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 84.0% year-over-year.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | +84.0% |
| FY2024 | $0.09 | +146.9% |
| FY2023 | -$0.20 | +42.9% |
| FY2022 | -$0.35 | -107.1% |
| FY2021 | -$0.17 | +50.1% |
| FY2020 | -$0.34 | +99.9% |
| FY2019 | -$371.02 | -206892.7% |
| FY2018 | -$0.18 | +31.4% |
| FY2017 | -$0.26 | -220.2% |
| FY2016 | -$0.08 | -306.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026